Brief: Lantheus Holdings Q3 Adjusted EPS USD 1.7 Vs. IBES Estimate USD 1.56
06/11/2024 12:00
Nov 06 (Reuters) - Lantheus Holdings Q3 EPS USD 1.79. * Q3 revenue USD 378.7 million vs. IBES estimate USD 371.7 million
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say